Bringing Zymergen to Scale: Enabling Engineering Biology with AI & Robotics – Data Collective

We're excited by Zymergen's latest funding of 130 million to aggressively scale its machine learning and applied robotics platform. This platform enables precision engineering biology at industrial scale and quality, optimizing existing products and producing breakthrough new ones in agriculture, life-sciences, and manufacturing. It was an easy decision for us to continue to invest in Zymergen, which we've backed since its seed. Their technology lead is huge and self-reinforcing, and they have an impressive number of global Fortune 500 customers, outstanding financial metrics, and a world-class team. We're pleased that this success attracted the support of SoftBank, which brings Deep Nishar to join us on the Zymergen Board.